Jesse Shefferman
CEO and President at Protara Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Protara Therapeutics Inc., 3 years.
Protara Therapeutics Inc.
Director · CEO and President
Chief executive roles
Protara Therapeutics Inc.
· CEO and President
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 19, 2024 | Protara Therapeutics Inc. | Grant or award | +59,000 | — | — |
| Jan 19, 2024 | Protara Therapeutics Inc. | Shares withheld for tax | −7,803 | $1.91 | $14,904 |
| Jan 10, 2024 | Protara Therapeutics Inc. | Shares withheld for tax | −5,746 | $2.39 | $13,733 |
| Jan 3, 2024 | Protara Therapeutics Inc. | Shares withheld for tax | −5,840 | $2.17 | $12,673 |
| Jun 27, 2023 | Protara Therapeutics Inc. | Gift | −7,420 | — | — |
| Jun 23, 2023 | Protara Therapeutics Inc. | Gift | −1,890 | — | — |
| Jan 19, 2023 | Protara Therapeutics Inc. | Grant or award | +51,300 | — | — |
| Jan 10, 2023 | Protara Therapeutics Inc. | Shares withheld for tax | −5,855 | $3.00 | $17,565 |
| Jan 3, 2023 | Protara Therapeutics Inc. | Shares withheld for tax | −6,604 | $2.80 | $18,491 |
| Jun 27, 2022 | Protara Therapeutics Inc. | Gift | −4,519 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.